CTC
LGND icon

Cetera Trust Company’s Ligand Pharmaceuticals LGND Stock Holding History

Cetera Trust Company’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$926K Buy
2,930
+50
+2% +$11.8K 0.46% 54
2026
Q1 		$575K Hold
2,880
– – 0.33% 62
2025
Q4 		$545K Hold
2,880
– – 0.29% 65
2025
Q3 		$510K Hold
2,880
– – 0.29% 68
2025
Q2 		$327K Buy
2,880
+225
+8% +$24K 0.2% 92
2025
Q1 		$279K Hold
2,655
– – 0.18% 109
2024
Q4 		$284K Buy
2,655
+75
+3% +$8.48K 0.18% 99
2024
Q3 		$258K Buy
2,580
+25
+1% +$2.52K 0.16% 131
2024
Q2 		$215K Buy
2,555
+75
+3% +$5.97K 0.14% 144
2024
Q1 		$181K Buy
2,480
+275
+12% +$20.3K 0.11% 176
2023
Q4 		$157K Buy
+2,205
New +$130K 0.1% 174

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cetera Trust Company's LGND Position: Q2 2026 in Review

Cetera Trust Company increased its Ligand Pharmaceuticals (LGND) stake by 1.7% in Q2 2026, buying an estimated $11.8K and bringing the position to 2,930 shares worth $926K. The position accounts for 0.46% of the portfolio, ranked #54.

Cetera Trust Company first reported a position in LGND in Q4 2023 and has held it in 11 quarters since. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Cetera Trust Company held 2,930 shares of Ligand Pharmaceuticals worth $926K as of Q2 2026.
  • Cetera Trust Company bought 50 Ligand Pharmaceuticals shares in Q2 2026, an estimated $11.8K.
  • Ligand Pharmaceuticals made up 0.46% of Cetera Trust Company's portfolio in Q2 2026, its #54 holding.
  • Cetera Trust Company first reported a position in Ligand Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.